State Street
NEPH icon

State Street’s Nephros NEPH Stock Holding History

State Street’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56K Hold
15,698
– – ﹤0.01% 4040
2026
Q1 		$46.8K Hold
15,698
– – ﹤0.01% 4136
2025
Q4 		$76.6K Hold
15,698
– – ﹤0.01% 4091
2025
Q3 		$74.3K Hold
15,698
– – ﹤0.01% 4098
2025
Q2 		$64.2K Hold
15,698
– – ﹤0.01% 4052
2025
Q1 		$27K Hold
15,698
– – ﹤0.01% 4171
2024
Q4 		$22.9K Hold
15,698
– – ﹤0.01% 4224
2024
Q3 		$26.8K Hold
15,698
– – ﹤0.01% 4192
2024
Q2 		$33.1K Hold
15,698
– – ﹤0.01% 4215
2024
Q1 		$34.4K Hold
15,698
– – ﹤0.01% 4219
2023
Q4 		$54.2K Hold
15,698
– – ﹤0.01% 4182
2023
Q3 		$23.5K Hold
15,698
– – ﹤0.01% 4426
2023
Q2 		$24.3K Hold
15,698
– – ﹤0.01% 4570
2023
Q1 		$17.1K Hold
15,698
– – ﹤0.01% 4702
2022
Q4 		$17.6K Hold
15,698
– – ﹤0.01% 4755
2022
Q3 		$14K Hold
15,698
– – ﹤0.01% 4870
2022
Q2 		$24K Buy
+15,698
New +$42.4K ﹤0.01% 4855

Other funds holding NEPH

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street's NEPH Position: Q2 2026 in Review

State Street held its Nephros (NEPH) position steady in Q2 2026 at 15,698 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

State Street first reported a position in NEPH in Q2 2022 and has held it in 17 quarters since. The position peaked at $76.6K in Q4 2025. 29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • State Street held 15,698 shares of Nephros worth $56K as of Q2 2026.
  • State Street left its Nephros share count unchanged in Q2 2026.
  • Nephros made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4040 holding.
  • State Street first reported a position in Nephros in Q2 2022 and has held it in 17 quarters since.
  • State Street's Nephros position peaked at $76.6K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.